Screening compound: InChI=1S/C18H14BrClN2OS/c1-2-22(17(23)14-5-3-4-6-15(14)20)18-21-16(11-24-18)12-7-9-13(19)10-8-12/h3-11H,2H2,1H3

Screening compound: InChI=1S/C18H14BrClN2OS/c1-2-22(17(23)14-5-3-4-6-15(14)20)18-21-16(11-24-18)12-7-9-13(19)10-8-12/h3-11H,2H2,1H3
Screening compound: InChI=1S/C18H14BrClN2OS/c1-2-22(17(23)14-5-3-4-6-15(14)20)18-21-16(11-24-18)12-7-9-13(19)10-8-12/h3-11H,2H2,1H3 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C18H14BrClN2OS/c1-2-22(17(23)14-5-3-4-6-15(14)20)18-21-16(11-24-18)12-7-9-13(19)10-8-12/h3-11H,2H2,1H3

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C301-6690

Molecular Formula

C18H14BrClN2OS (C18 H14 BrClN2 OS)

Compound Name

N-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-2-chloro-N-ethylbenzamide

IUPAC name

N-[4-(4-bromophenyl)-13-thiazol-2-yl]-2-chloro-N-ethylbenzamide

SMILES

CCN(C(c(cccc1)c1Cl)=O)c1nc(-c(cc2)ccc2Br)cs1

InChI

InChI=1S/C18H14BrClN2OS/c1-2-22(17(23)14-5-3-4-6-15(14)20)18-21-16(11-24-18)12-7-9-13(19)10-8-12/h3-11H,2H2,1H3

InChI Key

BLVRWJMGZYPRSB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD12129385

InChI=1S/C18H14BrClN2OS/c1-2-22(17(23)14-5-3-4-6-15(14)20)18-21-16(11-24-18)12-7-9-13(19)10-8-12/h3-11H,2H2,1H3 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Epigenetics Focused Set (26518 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Cancer
Targets:
  • Kinases
  • Proteases
Mechanism of action:
  • Epigenetic
  • PPI modulators

References: we are preparing a list of scientific research reports with InChI=1S/C18H14BrClN2OS/c1-2-22(17(23)14-5-3-4-6-15(14)20)18-21-16(11-24-18)12-7-9-13(19)10-8-12/h3-11H,2H2,1H3 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C18H14BrClN2OS/c1-2-22(17(23)14-5-3-4-6-15(14)20)18-21-16(11-24-18)12-7-9-13(19)10-8-12/h3-11H,2H2,1H3?
Check Price and Availability of InChI=1S/C18H14BrClN2OS/c1-2-22(17(23)14-5-3-4-6-15(14)20)18-21-16(11-24-18)12-7-9-13(19)10-8-12/h3-11H,2H2,1H3, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C18H14BrClN2OS/c1-2-22(17(23)14-5-3-4-6-15(14)20)18-21-16(11-24-18)12-7-9-13(19)10-8-12/h3-11H,2H2,1H3 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C18H14BrClN2OS/c1-2-22(17(23)14-5-3-4-6-15(14)20)18-21-16(11-24-18)12-7-9-13(19)10-8-12/h3-11H,2H2,1H3
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C18H14BrClN2OS/c1-2-22(17(23)14-5-3-4-6-15(14)20)18-21-16(11-24-18)12-7-9-13(19)10-8-12/h3-11H,2H2,1H3
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C18H14BrClN2OS/c1-2-22(17(23)14-5-3-4-6-15(14)20)18-21-16(11-24-18)12-7-9-13(19)10-8-12/h3-11H,2H2,1H3 available by request